MetLife, Inc. $MET Stock Sold by Cyndeo Wealth Partners LLC

Cyndeo Wealth Partners LLC trimmed its holdings in MetLife, Inc. (NYSE:MET) by 21.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 109,271 shares of the financial services provider’s stock after selling 29,450 shares during the quarter. Cyndeo Wealth Partners LLC’s holdings in MetLife were worth $10,289,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. BlackRock Inc. bought a new position in MetLife in the 2nd quarter valued at $4,381,692,000. Pzena Investment Management LLC bought a new stake in shares of MetLife during the second quarter worth $941,792,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of MetLife by 5.9% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 6,026,518 shares of the financial services provider’s stock valued at $509,904,000 after purchasing an additional 336,794 shares during the period. Bank of America Corp DE purchased a new stake in shares of MetLife during the second quarter valued at $455,424,000. Finally, Legal & General Group Plc purchased a new stake in shares of MetLife during the second quarter valued at $326,904,000. 94.99% of the stock is owned by institutional investors.

Analyst Ratings Changes

MET has been the topic of several recent analyst reports. Argus raised their price target on shares of MetLife from $93.00 to $109.00 and gave the stock a “buy” rating in a research note on Wednesday, September 2nd. Bank of America dropped their target price on shares of MetLife from $106.00 to $103.00 and set a “buy” rating on the stock in a research note on Wednesday, July 15th. UBS Group raised their target price on shares of MetLife from $105.00 to $110.00 and gave the stock a “buy” rating in a research report on Tuesday, October 6th. Wells Fargo & Company lifted their price target on shares of MetLife from $109.00 to $110.00 and gave the company an “overweight” rating in a research note on Monday, October 12th. Finally, Wall Street Zen upgraded MetLife from a “hold” rating to a “buy” rating in a report on Sunday, September 27th. Thirteen equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $105.19.

MetLife Stock Up 0.5%

NYSE:MET opened at $100.73 on Friday. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.20 and a quick ratio of 0.20. MetLife, Inc. has a 1-year low of $67.33 and a 1-year high of $102.43. The company has a 50-day moving average of $96.87 and a 200 day moving average of $88.73. The firm has a market cap of $64.82 billion, a PE ratio of 10.26, a price-to-earnings-growth ratio of 0.95 and a beta of 0.78.

MetLife (NYSE:MET) last posted its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $2.43 EPS for the quarter, beating the consensus estimate of $2.30 by $0.13. MetLife had a net margin of 4.57% and a return on equity of 23.39%. The business had revenue of $13.52 billion during the quarter, compared to analyst estimates of $19.67 billion. During the same quarter in the previous year, the business posted $2.02 EPS. The company’s quarterly revenue was up 10.5% compared to the same quarter last year. As a group, research analysts anticipate that MetLife, Inc. will post 9.93 EPS for the current fiscal year.

MetLife Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 8th. Shareholders of record on Tuesday, November 3rd will be issued a dividend of $0.5925 per share. The ex-dividend date is Tuesday, November 3rd. This represents a $2.37 dividend on an annualized basis and a yield of 2.4%. MetLife’s dividend payout ratio is currently 45.40%.

MetLife declared that its Board of Directors has initiated a share buyback plan on Wednesday, August 5th that authorizes the company to buy back $3.00 billion in shares. This repurchase authorization authorizes the financial services provider to repurchase up to 4.8% of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s board believes its shares are undervalued.

More MetLife News

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: JPMorgan raised its price target for MetLife from $108 to $110 and maintained an “overweight” rating. The new target implies approximately 9% upside from the referenced share price, signaling continued confidence in MetLife’s earnings outlook and valuation.
• Positive Sentiment: Dowling & Partners increased its FY2026 EPS forecast to $10.30 from $10.10. The revised estimate is also above the broader consensus forecast of $9.90, suggesting expectations for stronger profitability. MetLife Hits New 52-Week High on Analyst Upgrade
• Positive Sentiment: MetLife reached a new 52-week high following an analyst upgrade. The move reflects sustained investor demand and momentum around the insurer’s earnings performance and analyst outlook. MetLife Hits New 52-Week High on Analyst Upgrade
• Positive Sentiment: Brokerages’ consensus price target is reported at $105.06, providing additional evidence that analysts see potential upside for MET. MetLife Consensus Price Target
• Neutral Sentiment: MetLife Foundation awarded a $1 million grant to Ascendus for its Get Ready program. The initiative supports financial preparedness and may enhance MetLife’s corporate reputation, but it is unlikely to materially affect near-term earnings. Ascendus Expands Get Ready Program
• Neutral Sentiment: Articles about concerts, NFL venues and events at MetLife Stadium concern the stadium’s entertainment operations, not MetLife, Inc.’s insurance and financial-services business, so they are not expected to influence MET materially.

MetLife Profile

MetLife, Inc is a global financial services company that provides insurance, employee benefits and retirement solutions. Its products and services include life insurance, dental and vision coverage, disability insurance, accident and health benefits, annuities, and savings and retirement products.

The company serves individuals, employers and institutions through group benefits, workplace solutions and individual insurance offerings. MetLife also provides investment and retirement services designed to help employers and employees prepare for long-term financial needs.

Founded in 1868, MetLife is headquartered in New York City and operates through businesses in the United States and international markets, including regions across Latin America, Asia and Europe.